Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 May 1;73(9):811-8.
doi: 10.1016/j.biopsych.2012.12.020. Epub 2013 Jan 29.

The addictive dimensionality of obesity

Affiliations
Review

The addictive dimensionality of obesity

Nora D Volkow et al. Biol Psychiatry. .

Abstract

Our brains are hardwired to respond and seek immediate rewards. Thus, it is not surprising that many people overeat, which in some can result in obesity, whereas others take drugs, which in some can result in addiction. Though food intake and body weight are under homeostatic regulation, when highly palatable food is available, the ability to resist the urge to eat hinges on self-control. There is no homeostatic regulator to check the intake of drugs (including alcohol); thus, regulation of drug consumption is mostly driven by self-control or unwanted effects (i.e., sedation for alcohol). Disruption in both the neurobiological processes that underlie sensitivity to reward and those that underlie inhibitory control can lead to compulsive food intake in some individuals and compulsive drug intake in others. There is increasing evidence that disruption of energy homeostasis can affect the reward circuitry and that overconsumption of rewarding food can lead to changes in the reward circuitry that result in compulsive food intake akin to the phenotype seen with addiction. Addiction research has produced new evidence that hints at significant commonalities between the neural substrates underlying the disease of addiction and at least some forms of obesity. This recognition has spurred a healthy debate to try and ascertain the extent to which these complex and dimensional disorders overlap and whether or not a deeper understanding of the crosstalk between the homeostatic and reward systems will usher in unique opportunities for prevention and treatment of both obesity and drug addiction.

PubMed Disclaimer

Conflict of interest statement

The authors report no biomedical financial interests or potential conflicts of interest.

Figures

Figure 1
Figure 1
In striking contrast to drugs whose actions are triggered by their direct pharmacologic effects in the brain reward dopamine pathway (ventral tegmental area [VTA], nucleus accumbens, and ventral pallidum), the regulation of eating behaviors and hence the responses to food are modulated by multiple peripheral and central mechanisms that directly or indirectly convey into the brain’s reward pathways, including those involved with pleasure, aversion, habituation, and cognitive control [Diagram of the organization of striatocortical connectivity loops reprinted with permission from Haber et al. (112), copyright 2000 Society for Neuroscience]. PYY, peptide YY; s. intestines, small intestines; SN, substantia nigra.
Figure 2
Figure 2
Schematic representation of bowtie architectures in the brain as exemplified by the (A) energy homeostatic (metabolic) and (B) dopamine reactive (reward) systems. The human brain, like most complex biological systems, is characterized by the layered architectures of interactive networks [reprinted with permission from (111), copyright 2004 Elsevier]. These systems display an evolutionarily optimized organization, whereby a narrowing funnel of many potential inputs converges onto a relatively small number of processes before fanning out again into a great diversity of outputs. (C) The homeostatic and reward bowties are good examples of nested layered architectures [reprinted with permission from (111), copyright 2004 Elsevier], since the dopamine bowtie can be viewed as an integral part of the broader energetic network that includes hypothalamic (HYP) signaling and peripheral hormones. NAc, nucleus accumbens; PFC, prefrontal cortex; SN, substantia nigra; VTA, ventral tegmental area (modified with permission from an unpublished presentation, courtesy of Dr. John Doyle, Ph.D.).

Comment in

References

    1. Naukkarinen J, Surakka I, Pietilainen KH, Rissanen A, Salomaa V, Ripatti S, et al. Use of genome-wide expression data to mine the “Gray Zone” of GWA studies leads to novel candidate obesity genes. PLoS Genet. 2010;6:e1000976. - PMC - PubMed
    1. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42:937–948. - PMC - PubMed
    1. de Krom M, Bauer F, Collier D, Adan RA, la Fleur SE. Genetic variation and effects on human eating behavior. Annu Rev Nutr. 2009;29:283–304. - PubMed
    1. Blum K, Braverman ER, Wood RC, Gill J, Li C, Chen TJ, et al. Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: A preliminary report. Pharmacogenetics. 1996;6:297–305. - PubMed
    1. Schleinitz D, Carmienke S, Bottcher Y, Tonjes A, Berndt J, Kloting N, et al. Role of genetic variation in the cannabinoid type 1 receptor gene (CNR1) in the pathophysiology of human obesity. Pharmacogenomics. 2010;11:693–702. - PubMed

Publication types